Cotargeting of Bcl-2 and Mcl-1 Shows Promising Antileukemic Activity against AML Cells Including those with Acquired Cytarabine Resistance
Cotargeting of Bcl-2 and Mcl-1 Shows Promising Antileukemic Activity against AML Cells Including those with Acquired Cytarabine Resistance
复制标题
Bcl-2 和 Mcl-1 的共靶向显示出针对 AML 细胞（包括获得性阿糖胞苷耐药细胞）的良好抗白血病活性
DOI：
10.1016/j.exphem.2021.10.00
复制
发表时间：
2022
影响因子：
2.6
通讯作者：
Wang Guan
中科院分区：
文献类型：
--
作者：
Liu Fangbing;Zhao Qiushi;Su Yongwei;Lv Jing;Gai Yuqing;Liu Shuang;Lin Hai;Wang Yue;Wang Guan
